Aprazer Healthcare Launched Imatikast

September 29, 2021
Posted by Aprazer

21 Dec

Launch Date: 21-12-2019

Aprazer Healthcare Launched IMATIKAST (IMATINIB ) which is a medication used to treat
• Myelodysplastic/Myeloproliferative Diseases.
• Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukemia.
• Chronic Myeloid Leukemia Philadelphia-Chromosome-positive.
• Dermatofibrosarcoma Protuberans.
• Mastocytosis.
• Gastrointestinal Stromal Tumors.

Newer Aprazer Healthcare Launched SORAFEKAST

Older Aprazer Healthcare Launched HEPAKAST

Disclaimer : This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. The website does not sell/ purchase any medicine.